ATE521362T1 - Wundheilungspeptide und verfahren zur verwendung davon - Google Patents

Wundheilungspeptide und verfahren zur verwendung davon

Info

Publication number
ATE521362T1
ATE521362T1 AT09701241T AT09701241T ATE521362T1 AT E521362 T1 ATE521362 T1 AT E521362T1 AT 09701241 T AT09701241 T AT 09701241T AT 09701241 T AT09701241 T AT 09701241T AT E521362 T1 ATE521362 T1 AT E521362T1
Authority
AT
Austria
Prior art keywords
methods
wound healing
healing peptides
relates
peptides
Prior art date
Application number
AT09701241T
Other languages
English (en)
Inventor
Ira Herman
Original Assignee
Univ Tufts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Tufts filed Critical Univ Tufts
Application granted granted Critical
Publication of ATE521362T1 publication Critical patent/ATE521362T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT09701241T 2008-01-08 2009-01-08 Wundheilungspeptide und verfahren zur verwendung davon ATE521362T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1040108P 2008-01-08 2008-01-08
PCT/US2009/030463 WO2009089368A1 (en) 2008-01-08 2009-01-08 Wound healing peptides and methods of use thereof

Publications (1)

Publication Number Publication Date
ATE521362T1 true ATE521362T1 (de) 2011-09-15

Family

ID=40736024

Family Applications (1)

Application Number Title Priority Date Filing Date
AT09701241T ATE521362T1 (de) 2008-01-08 2009-01-08 Wundheilungspeptide und verfahren zur verwendung davon

Country Status (5)

Country Link
US (2) US8357655B2 (de)
EP (1) EP2244719B1 (de)
AT (1) ATE521362T1 (de)
CA (1) CA2711133A1 (de)
WO (1) WO2009089368A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016094675A1 (en) 2014-12-12 2016-06-16 Smith & Nephew, Inc. Use of clostridium histolyticum protease mixture in promoting wound healing
CN112138208A (zh) * 2020-09-28 2020-12-29 深圳清华大学研究院 促血管化组织再生的支架材料及其制备方法
US12059430B2 (en) 2022-09-29 2024-08-13 Adora Animal Health Corporation Storage stable formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3267006A (en) * 1962-04-20 1966-08-16 Armour Pharma Pancreatic collagenase and preparation of same
US5124155A (en) * 1988-06-21 1992-06-23 Chiron Ophthalmics, Inc. Fibronectin wound-healing dressings
CA2046802C (en) * 1990-08-15 2007-05-22 Donald Zane Fortney Compositions containing protease produced by vibrio and method of use in debridement and wound healing
US5718897A (en) * 1995-06-07 1998-02-17 Trustees Of Tufts College Enhancing keratinocyte migration and proliferation
US5851522A (en) * 1995-06-07 1998-12-22 Trustees Of Tufts College Enhancing keratinocyte migration
GB2321191B (en) * 1997-01-17 2000-09-27 Johnson & Johnson Medical Peptides for use in wound treatment
US7691829B2 (en) * 1998-03-24 2010-04-06 Petito George D Composition and method for healing tissues
US6277588B1 (en) * 1998-05-01 2001-08-21 Tel Aviv University Screening of cell populations
US20050255107A1 (en) * 1998-06-17 2005-11-17 Beth Israel Deaconess Medical Center Anti-angiogenic proteins and fragments and methods of use thereof
US6124260A (en) * 1998-09-30 2000-09-26 Cedars-Sinai Medical Center Inhibition of smooth muscle cell migration by Tenascin-C peptides
US20070003541A1 (en) * 2005-07-01 2007-01-04 Rodolfo Faudoa Methods and compositions for therapeutics
WO2008016673A2 (en) * 2006-08-01 2008-02-07 Thefeinstein Institute For Medical Research Bioactive scaffolds

Also Published As

Publication number Publication date
US20130108614A1 (en) 2013-05-02
WO2009089368A1 (en) 2009-07-16
US20110110922A1 (en) 2011-05-12
EP2244719B1 (de) 2011-08-24
CA2711133A1 (en) 2009-07-16
US8663617B2 (en) 2014-03-04
EP2244719A1 (de) 2010-11-03
US8357655B2 (en) 2013-01-22

Similar Documents

Publication Publication Date Title
UA106586C2 (uk) Анти-cd79b антитіла, і імунокон'югати та способи їх застосування
JO2976B1 (en) Axentomodulin polypeptide
EP4241767C0 (de) Neuartige lipide und zusammensetzungen zur verabreichung von therapeutika
MX2013003681A (es) Ácidos nucleicos manipulados y métodos de uso de los mismos.
EP2408921A4 (de) Modifikation von cxcr4 mit manipulierten zink-fingerproteinen
BR112014032316A2 (pt) proteínas de repetição de anquirina projetadas que se ligam ao fator de crescimento derivado de plaqueta
CR20110470A (es) Proteínas de union a il-17
MX392483B (es) Proteínas de dominio de armazón basadas en fibronectina que se unen a la proteína convertasa subtilisina kexina tipo q (pcsk9).
MX2012001346A (es) Polipeptidos del factor ix modificados y usos de los mismos.
EP2274442A4 (de) Konsensussequenzen von chikungunya-virusproteinen, dafür codierende nukleinsäuremoleküle und zusammensetzungen und verfahren zur verwendung davon
EP4130273C0 (de) Herstellung heterologer polypeptide in mikroalgen, extrazelluläre algenkörper, zusammensetzungen und verfahren zur herstellung sowie verwendungen davon
DE602008004889D1 (de) Verfahren zur herstellung von ethylenoxid und ethylenglykol
EP2502939A4 (de) Unnatürliches collagen-artiges protein und seine verwendung
MX387756B (es) Composiciones de matríces extracelulares.
ATE423565T1 (de) Verwendung von substanz p zur mobilisierung und proliferation mesenchymaler stammzellen und zur wundheilung
NZ715203A (en) Heparan sulphates
DE112009001253A5 (de) Verfahren und Kit zur Dotierung oder Einfärbung von porösen Keramiken
EP4017468A4 (de) Materialien zur abgabe von bindefähigen proteinen in knochenimplantaten
EA201290541A1 (ru) Модифицированные бычьи соматотропиновые полипептиды и их применение
MX371403B (es) Moleculas de andamiaje a base de fibronectina estabilizada.
CY1115714T1 (el) Συνθεσεις και μεθοδοι για τη θεραπεια της πολλαπλης σκληρυνσης
EA201300127A1 (ru) Комбинированная фармацевтическая композиция и способ лечения головокружения различного генеза, кинетоза и вегетососудистой дистонии
EP2497784A4 (de) Peptid zur förderung einer zellproliferation und verwendung davon
EP3871674C0 (de) Verwendung von anatabin zur reduzierung des blutserumspiegels von c-reaktivem protein bei einem individuum
EA201290542A1 (ru) Модифицированные свиные соматотропиновые полипептиды и их применение

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties